AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 29 filers reported holding AGILE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 265 | -97.7% | 0.00% | – |
| Q4 2021 | $5,000 | -80.8% | 11,554 | -41.7% | 0.00% | – |
| Q3 2021 | $26,000 | 0.0% | 19,811 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | +100.0% | 19,811 | +169.7% | 0.00% | – |
| Q1 2020 | $13,000 | -66.7% | 7,346 | -54.0% | 0.00% | – |
| Q4 2019 | $39,000 | +3800.0% | 15,981 | +1167.3% | 0.00% | – |
| Q1 2019 | $1,000 | – | 1,261 | +1161.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 100 | -99.7% | 0.00% | – |
| Q2 2018 | $17,000 | +1600.0% | 36,070 | +7367.9% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 483 | -55.2% | 0.00% | – |
| Q3 2017 | $4,000 | – | 1,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 31,839,850 | $42,348,000 | 0.28% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $978,000 | 0.14% |
| INVESTOR AB | 3,510,189 | $4,669,000 | 0.14% |
| Tibra Equities Europe Ltd | 241,100 | $321,000 | 0.10% |
| FIRST MIDWEST BANK TRUST DIVISION | 349,158 | $464,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 372,543 | $495,000 | 0.06% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 110,000 | $146,000 | 0.04% |
| Kalos Management, Inc. | 19,250 | $24,000 | 0.01% |
| Summit Global Investments | 110,100 | $146,000 | 0.01% |
| Founders Capital Management | 10,000 | $13,000 | 0.01% |